Vincent Chak
YOU?
Author Swipe
View article: Phosphatidylserine exposure on tolerogenic nanoparticle correlate with oral tolerance
Phosphatidylserine exposure on tolerogenic nanoparticle correlate with oral tolerance Open
Unwanted immune responses against therapeutic proteins compromise treatment safety and therapeutic efficacy in patients. To mitigate these immune responses, we developed phosphatidylserine (PS)-containing lipid nanoparticles that mimic the…
View article: Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines
Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines Open
COVID-19, the disease caused by the novel severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2), was first detected in December 2019 and has since morphed into a global pandemic claiming over 2.4 million human lives and s…